Best Angiotensin Converting Enzyme Inhibitor for ventricular dysfunction, left
4 Angiotensin Converting Enzyme Inhibitor drugs indicated for ventricular dysfunction, left, ranked by our independent rating. The current highest-rated is qbrelis. Compare them with all treatments for ventricular dysfunction, left or the full Angiotensin Converting Enzyme Inhibitor class. Not medical advice — always consult a professional.
Top angiotensin converting enzyme inhibitor for ventricular dysfunction, left: 1. Qbrelis · 2. Lotensin · 3. Lotensin Hct
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Qbrelis | 72/100 | Prescription | $1 | View → |
| 2 | Lotensin | 70/100 | Prescription | $2 | View → |
| 3 | Lotensin Hct |
Full ranking · 4 drugs
Frequently asked
- What is the best angiotensin converting enzyme inhibitor for ventricular dysfunction, left?
- By our independent rating, qbrelis currently ranks highest among Angiotensin Converting Enzyme Inhibitor drugs used for ventricular dysfunction, left. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which angiotensin converting enzyme inhibitor drugs treat ventricular dysfunction, left?
- pharmaranks lists 4 Angiotensin Converting Enzyme Inhibitor products indicated for ventricular dysfunction, left, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.